RSS
Press Releases
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
VANCOUVER, British Columbia, June 14, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today presented new clinical data from the dose-escalation portion of its ongoing Phase 1 study evaluating ZW191, a folate receptor alpha (FRα)-targeting antibody-drug…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies show PALSONIFY maintained lower IGF-1 levels and stable symptoms Treatment also resulted in stable or reduced pituitary tumor volumes for up to 48 weeks
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
LOS ANGELES, June 14, 2026 (GLOBE NEWSWIRE) -- As the Bitcoin ecosystem gains global momentum, AIXAlpha is proud to introduce a major leap in accessible AI-driven participation: the launch of BTC-focused AI Strategy Contracts.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
HAMPTON, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today presented positive results from the Phase 1 healthy participant study of CDX-622, a novel, bispecific antibody that targets soluble SCF and TSLP, at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Istanbul, Türkiye. Data demonstrated that CDX-622 induced rapid, durable, dose-dependent…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15 to 18, King Faisal Specialist Hospital & Research Centre (KFSH) will highlight that the value of artificial intelligence in healthcare is measured not by technological complexity alone, but by its ability to give clinicians more…
Globe NewsWire News Distribution Service Article Count: 1557
Media Partner Network Article Count: 4
Send2Press NewsWire Distribution Service Article Count: 541
Related Product Search/Búsqueda de productos relacionados
